Clean Earth (CLIN) Lowers Alternus Valuation in Deal Tweak
by Marlena Haddad on 2023-04-18 at 5:57pm

Clean Earth Acquisitions Corp. (NASDAQ:CLIN) announced in an 8-K this afternoon that it has lowered the valuation for its climate technology target Alternus (OSE:ALT) and reduced the earnout shares for the deal.

At deal announcement, Alternus had a pre-money valuation of $550 million and Clean Earth originally agreed to issue Alternus Energy a number of shares equal to $550 million plus or minus an estimated working capital adjustment, of which 1,000,000 shares would be deposited into a working capital escrow account to satisfy any post-closing working capital adjustments.

But, the parties have now agreed to reduce this valuation by 50%, from $550 million to $275 million.

As a result of this change, Clean Earth will issue a number of shares to Alternus equal to $275 million, plus or minus an estimated working capital adjustment of which 1,000,000 shares will be deposited into a working capital escrow account.

Additionally, the parties have agreed to reduce the earnout shares from 35 million shares to 20 million shares and modify the earnout milestones.

These shares will be deposited into an earnout escrow account and will be released to Alternus if the Adjusted EBITDA for the fiscal year ending on December 31, 2023 is at least $16 million and the company’s share price is at least $11.00 for a minimum number of trading days, then 6,000,000 shares will be released. If Adjusted EBITDA for the fiscal year ending on December 31, 2024 is at least $52 million and the company’s share price is at least $13.00 for a minimum number of trading days, then 6,000,000 shares will be released. And if Adjusted EBITDA for the fiscal year ending on December 31, 2025 is at least $156 million and the company’s share price is at least $15.00 for a minimum number of trading days, then 8,000,000 earnout shares will be released to Alternus.

If any of the earnout milestones are not met, the earnout shares that would have been released to the seller will be released if a subsequent earnout milestone is met. In addition, if any earnout milestone based on Adjusted EBITDA has been met, but the corresponding earnout milestone based on share price has not been met, the shares may be released if share price targets or a calculated share price based on a multiple of Adjusted EBITDA reduced by net debt are met during the five-year period from the date of the applicable milestone.

Furthermore, Citigroup, one of the underwriters of Clean Earth’s IPO, agreed to forfeit the remaining deferred discount payment of $3,622,500 that is to be paid to them upon the consummation of a business combination, such that when taken together with that certain letter agreement, Citigroup agrees to forfeit the entire deferred discount payment of $7,245,000.

Clean Earth announced its $992 million deal with Alternus in October 2022. Dublin, Ireland-based Alternus installs, owns and operates midsized utility scale solar plants and plans to have about 3.5 GW of generation assets in this portfolio by 2025.

Recent Posts
by Nicholas Alan Clayton on 2024-05-03 at 3:56pm

Real estate marketplace Opendoor (NASDAQ:OPEN) is poised to be the latest de-SPAC to take a double-digit jump on earnings as it heads towards the weekend up +10%, having spiked as high as +27% earlier in the day. The movement comes as the former Social Capital II target reported progress towards profitability despite a high rates...

by Nicholas Alan Clayton on 2024-05-03 at 8:02am

At the SPAC of Dawn Coinbase (NASDAQ:COIN) notched a surprise profit of over $1.5 billion in the first quarter of 2024, well exceeding estimates, demonstrating the powerful effect of publicly traded ETFs have had on crypto marketplaces since the start of the year. The result has pushed the company to bump up its own guidance...

by Nicholas Alan Clayton on 2024-05-02 at 3:03pm

Online casino and sports company Rush Street (NYSE:RSI) is up +18.4% in trading today on the back of a solid first quarter earnings release, bringing the company’s stock to its highest price since the second half of 2022 (currently $7.60). This makes it the latest in a line of 2020 and 2021 de-SPACs that have...

by Nicholas Alan Clayton on 2024-05-02 at 10:56am

Mountain Crest V (NASDAQ:MCAG) broke a long dealmaking silence by SPACs this morning, albeit with a non-binding agreement to combine with Seoul-based diagnostic biotech firm CUBEBIO. The term sheet would give the company a $620 million pre-transaction equity value and help accelerate the rollout of CUBEBIO’s CEED-NOVUS cancer screening kit products. The company signed an...

by Nicholas Alan Clayton on 2024-05-02 at 8:45am

Churchill Capital Corp IX (NASDAQ:CCIXU) announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CCIXU”, Thursday, May 2, 2024. The new SPAC will conduct a broad search and has not limited itself to any particular sector or focus, but it plans to...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved